JP2005506298A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005506298A5 JP2005506298A5 JP2002576907A JP2002576907A JP2005506298A5 JP 2005506298 A5 JP2005506298 A5 JP 2005506298A5 JP 2002576907 A JP2002576907 A JP 2002576907A JP 2002576907 A JP2002576907 A JP 2002576907A JP 2005506298 A5 JP2005506298 A5 JP 2005506298A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- composition
- group
- arylalkyl
- heteroarylalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27995601P | 2001-03-29 | 2001-03-29 | |
| US28036601P | 2001-03-30 | 2001-03-30 | |
| PCT/US2002/009817 WO2002078639A2 (en) | 2001-03-29 | 2002-03-28 | A method of treating proliferative diseases using eg5 inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005506298A JP2005506298A (ja) | 2005-03-03 |
| JP2005506298A5 true JP2005506298A5 (https=) | 2005-12-22 |
Family
ID=26959985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002576907A Withdrawn JP2005506298A (ja) | 2001-03-29 | 2002-03-28 | Ｅｇ５阻害剤を用いる増殖性疾患の治療方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20020165240A1 (https=) |
| EP (1) | EP1372657A4 (https=) |
| JP (1) | JP2005506298A (https=) |
| CA (1) | CA2442455A1 (https=) |
| IL (1) | IL158083A0 (https=) |
| MX (1) | MXPA03008691A (https=) |
| WO (1) | WO2002078639A2 (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040009156A1 (en) * | 2001-10-12 | 2004-01-15 | Christoph Reinhard | Antisense therapy using oligonucleotides that target human kinesin genes for treatment of cancer |
| ATE480527T1 (de) * | 2001-12-11 | 2010-09-15 | Kyowa Hakko Kirin Co Ltd | Thiadiazolinderivate zur krebsbehandlung |
| US7199107B2 (en) | 2002-05-23 | 2007-04-03 | Isis Pharmaceuticals, Inc. | Antisense modulation of kinesin-like 1 expression |
| CA2522594C (en) * | 2003-04-18 | 2012-01-24 | Kyowa Hakko Kogyo Co., Ltd. | Mitotic kinesin inhibitor |
| US20070276017A1 (en) * | 2003-06-10 | 2007-11-29 | Chikara Murakata | Thiadiazoline Derivative |
| US7166603B2 (en) | 2003-07-23 | 2007-01-23 | Bristol-Myers Squibb Co. | Dihydropyrimidone inhibitors of calcium channel function |
| WO2005007124A2 (en) | 2003-07-23 | 2005-01-27 | Bristol-Myers Squibb Company | Substituted dihydropyrimidine inhibitors of calcium channel function |
| US20050158320A1 (en) * | 2003-11-12 | 2005-07-21 | Nichols M. J. | Combinations for the treatment of proliferative diseases |
| US20050100508A1 (en) * | 2003-11-12 | 2005-05-12 | Nichols M. J. | Methods for identifying drug combinations for the treatment of proliferative diseases |
| US7662581B1 (en) | 2003-12-18 | 2010-02-16 | Novartis Vaccines And Diagnostics, Inc. | Eg5 co-crystals |
| ATE507220T1 (de) * | 2003-12-20 | 2011-05-15 | Merck Patent Gmbh | Tetrahydropyranochinolinderivate |
| ATE496142T1 (de) * | 2004-03-23 | 2011-02-15 | Oncotherapy Science Inc | Verfahren zur diagnose von nicht-kleinzelligem lungenkrebs |
| DE102004021637A1 (de) * | 2004-05-03 | 2005-12-01 | Merck Patent Gmbh | Dihydrobenzothiophene |
| CN101027309B (zh) | 2004-08-18 | 2010-10-27 | 阿斯利康(瑞典)有限公司 | 所选择的稠合嘧啶酮的对映体和在治疗和预防癌症中的用途 |
| US20100152206A1 (en) * | 2005-01-07 | 2010-06-17 | Ralph Mazitschek | Bicyclic Dihydropyrimidines and Uses Thereof |
| EP1870404A4 (en) * | 2005-03-22 | 2010-07-14 | Kyowa Hakko Kirin Co Ltd | MEANS FOR THE TREATMENT OF A HEMATOPOIETIC TUMOR |
| WO2006101102A1 (ja) * | 2005-03-22 | 2006-09-28 | Kyowa Hakko Kogyo Co., Ltd. | 固形腫瘍治療剤 |
| EP1908755A4 (en) * | 2005-06-24 | 2009-06-24 | Kyowa Hakko Kirin Co Ltd | THERAPEUTIC AGENT AGAINST RESTENOSIS |
| DE102006002065B4 (de) * | 2006-01-16 | 2007-11-29 | Infineon Technologies Austria Ag | Kompensationsbauelement mit reduziertem und einstellbarem Einschaltwiderstand |
| JP5385125B2 (ja) | 2006-03-22 | 2014-01-08 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ＭＤＭ２とｐ５３の間の相互作用の阻害剤 |
| CN102316877A (zh) * | 2008-05-30 | 2012-01-11 | 达那-法伯癌症研究所 | 治疗减数分裂驱动蛋白相关疾病的方法 |
| US8703802B2 (en) | 2010-05-20 | 2014-04-22 | Targacept, Inc. | Process for the preparation of aryl substituted olefinic amines |
| RU2427373C1 (ru) * | 2010-11-08 | 2011-08-27 | Виктор Вениаминович Тец | Средство для индукции эндогенного интерферона |
| CN113135859B (zh) * | 2021-04-26 | 2022-08-26 | 安徽省庆云医药股份有限公司 | 一种绿色合成瑞舒伐他汀钙中间体的方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2658804A1 (de) * | 1976-12-24 | 1978-07-06 | Bayer Ag | Kreislaufbeeinflussende mittel |
| EP0330470A3 (en) * | 1988-02-24 | 1992-01-02 | Ajinomoto Co., Inc. | 1,4-dihydropyridine derivatives useful against tumour cells |
| US5536724A (en) * | 1992-03-03 | 1996-07-16 | Sri International | Antiinflammatory and antineoplastic 5-deazaaminopterins and 5,10-dideazaaminopterins |
| US5767131A (en) * | 1993-04-05 | 1998-06-16 | Synaptic Pharmaceutical Corporation | Dihydropyridines and new uses thereof |
-
2002
- 2002-03-28 IL IL15808302A patent/IL158083A0/xx unknown
- 2002-03-28 EP EP02717741A patent/EP1372657A4/en not_active Withdrawn
- 2002-03-28 CA CA002442455A patent/CA2442455A1/en not_active Abandoned
- 2002-03-28 WO PCT/US2002/009817 patent/WO2002078639A2/en not_active Ceased
- 2002-03-28 US US10/108,403 patent/US20020165240A1/en not_active Abandoned
- 2002-03-28 MX MXPA03008691A patent/MXPA03008691A/es unknown
- 2002-03-28 JP JP2002576907A patent/JP2005506298A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005506298A5 (https=) | ||
| JP2004519469A5 (https=) | ||
| JP2004531544A5 (https=) | ||
| RU2007130532A (ru) | Дизамещенные мочевины в качестве ингибиторов киназы | |
| JP2007520440A5 (https=) | ||
| RU2003119153A (ru) | Орто-, мета-замещенные бис-арильные соединения, способ их получения, их применение в качестве медикаментов, а также содержащие их фармацевтические композиции | |
| NO20072515L (no) | 2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav | |
| JP2004535436A5 (https=) | ||
| JP2006151984A5 (https=) | ||
| DE60316686D1 (de) | Bisarylsulfonamid-derivate und ihre verwendung für krebs therapie | |
| RU2007101685A (ru) | Модуляторы никотиновых ацетилхолиновых рецепторов альфа 7 и их терапевтические применения | |
| JP2012505879A5 (https=) | ||
| RU2007129090A (ru) | Органические соединения | |
| JP2004516314A5 (https=) | ||
| RU2005114021A (ru) | Производные имидазола и их применение в качестве периферически-селективных ингибиторов дофамин-бета-гидролазы | |
| JP2005511699A5 (https=) | ||
| RU2008126245A (ru) | Комбинация ингибитора асне и антагониста 5-нт для лечения когнитивной дисфункции | |
| JP2006503850A5 (https=) | ||
| JP2005526024A5 (https=) | ||
| ES2373561T3 (es) | Uso de derivados de 1,4-bis(3-aminoalquil)piperazina en el tratamiento de enfermedades neurodegenerativas. | |
| AR040126A1 (es) | Compuesto de fenilsulfonilo, composicion farmaceutica que lo comprende y su uso para la elaboracion de un medicamento | |
| JP2004534781A5 (https=) | ||
| RU2002130247A (ru) | Производные оксадиазола, обладающие противоопухолевым действием | |
| JP2005505583A5 (https=) | ||
| RU2010116779A (ru) | Производное амида индазолакриловой кислоты |